Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
Max Herzberg is a veteran entrepreneur and angel investor in Israeli biopharmaceuticals, known for his focus on biotech companies. He has been involved in founding and managing several biotech ventures and has a track record of investing in Israeli startups. He was also the CEO of the Israel Biodiscovery Fund.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
1 portfolio exit on record.
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is Max Herzberg's primary investment focus?
- Max Herzberg primarily invests in biotech companies, specializing in the Health Tech & Life Sciences sector.
- Can you name a notable exit for Max Herzberg?
- Max Herzberg had an exit with VBL Therapeutics, which went public on NASDAQ in October 2014 with a valuation of $120M.
- Which company is a key part of Max Herzberg's portfolio?
- A key company in Max Herzberg's portfolio is VBL Therapeutics, a B2B company founded in 2000 that focuses on targeted therapies for immune-inflammatory diseases.
- What is the total capital raised by VBL Therapeutics, a company in Max Herzberg's portfolio?
- VBL Therapeutics, a portfolio company of Max Herzberg, has raised $109.77M in total funding.
- When did Max Herzberg make a notable investment?
- Max Herzberg made a notable investment in October 2010, which also marked the addition of a new portfolio company.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Radar intelligence
Patents
| EPO | 17 |
|---|